Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Encompass Health Corp (EHC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Encompass Health Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 785161.
Total stock buying since 2015: $10,987,295.
Total stock sales since 2015: $54,155,618.
Total stock option exercises since 2015: $27,658,884.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 182,300 | $21,655,888 | 171,959 | $6,420,803 |
| 2024 | 2,000 | $167,460 | 81,779 | $6,878,786 | 71,779 | $2,321,140 |
| 2023 | 0 | $0 | 62,734 | $4,175,621 | 59,848 | $1,473,003 |
| 2022 | 2,830 | $166,526 | 20,449 | $1,088,909 | 46,581 | $959,705 |
| 2021 | 354 | $20,039 | 8,589 | $699,144 | 0 | $0 |
| 2020 | 166,000 | $9,882,544 | 60,783 | $4,182,876 | 49,633 | $1,118,253 |
| 2019 | 1,500 | $93,435 | 67,382 | $4,277,746 | 67,382 | $1,268,129 |
| 2018 | 0 | $0 | 108,189 | $7,341,459 | 36,997 | $424,366 |
| 2017 | 1,000 | $45,950 | 45,250 | $1,935,568 | 60,250 | $1,084,066 |
| 2016 | 13,620 | $531,353 | 47,240 | $1,869,420 | 332,000 | $8,366,838 |
| 2015 | 2,294 | $79,988 | 1,145 | $50,201 | 162,029 | $4,222,581 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 1,020 | $126,061 | 0 | $0 |
| 2025-05 | 0 | $0 | 122,663 | $14,851,258 | 118,384 | $4,719,378 |
| 2025-04 | 0 | $0 | 53,575 | $6,182,991 | 53,575 | $1,701,425 |
| 2025-02 | 0 | $0 | 5,042 | $495,578 | 0 | $0 |
| 2024-08 | 0 | $0 | 12,260 | $1,062,696 | 12,260 | $439,275 |
| 2024-05 | 2,000 | $167,460 | 24,543 | $2,070,939 | 14,543 | $422,619 |
| 2024-04 | 0 | $0 | 44,976 | $3,745,151 | 44,976 | $1,459,246 |
| 2023-11 | 0 | $0 | 11,215 | $710,918 | 16,623 | $441,340 |
| 2023-08 | 0 | $0 | 33,624 | $2,377,045 | 25,330 | $672,511 |
| 2023-02 | 0 | $0 | 17,895 | $1,087,658 | 17,895 | $359,152 |
| 2022-10 | 1,830 | $100,046 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 20,449 | $1,088,909 | 20,449 | $410,411 |
| 2022-05 | 1,000 | $66,480 | 0 | $0 | 0 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 26,132 | $549,294 |
| 2021-12 | 354 | $20,039 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 8,589 | $699,144 | 0 | $0 |
| 2020-11 | 0 | $0 | 6,650 | $500,213 | 0 | $0 |
| 2020-05 | 0 | $0 | 52,133 | $3,564,583 | 49,633 | $1,118,253 |
| 2020-03 | 166,000 | $9,882,544 | 2,000 | $118,080 | 0 | $0 |
| 2019-11 | 500 | $34,595 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 67,382 | $4,277,746 | 67,382 | $1,268,129 |
| 2019-03 | 1,000 | $58,840 | 0 | $0 | 0 | $0 |
| 2018-08 | 0 | $0 | 38,412 | $3,015,428 | 0 | $0 |
| 2018-05 | 0 | $0 | 69,777 | $4,326,031 | 36,997 | $424,366 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-27 | Tuer Patrick William (EVP, Chief Operating Officer) | Sale | 1,020 | 123.59 | 126,061 |
| 2025-05-20 | Tarr Mark J (President & CEO) | Sale | 118,384 | 121.23 | 14,352,284 |
| 2025-05-20 | Tarr Mark J (President & CEO) | Option Ex | 118,384 | 39.87 | 4,719,378 |
| 2025-05-06 | Charbonneau Elissa Joy (Chief Medical Officer) | Sale | 4,279 | 116.61 | 498,974 |
| 2025-04-29 | Darby John Patrick (EVP, Gen Counsel & Secretary) | Sale | 10,000 | 114.79 | 1,147,900 |
| 2025-04-29 | Darby John Patrick (EVP, Gen Counsel & Secretary) | Option Ex | 10,000 | 35.06 | 350,600 |
| 2025-04-29 | Coltharp Douglas E (EVP & Chief Financial Officer) | Sale | 43,575 | 115.55 | 5,035,091 |
| 2025-04-29 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 43,575 | 31.00 | 1,350,825 |
| 2025-02-13 | Price Andrew L (Chief Accounting Officer) | Sale | 5,042 | 98.29 | 495,578 |
| 2024-08-13 | Coltharp Douglas E (EVP & Chief Financial Officer) | Sale | 12,260 | 86.68 | 1,062,696 |
| 2024-08-13 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 12,260 | 35.83 | 439,275 |
| 2024-05-24 | Charbonneau Elissa Joy (Chief Medical Officer) | Sale | 10,000 | 85.02 | 850,200 |
| 2024-05-06 | Darby John Patrick (EVP, Gen Counsel & Secretary) | Sale | 14,543 | 83.94 | 1,220,739 |
| 2024-05-06 | Darby John Patrick (EVP, Gen Counsel & Secretary) | Option Ex | 14,543 | 29.06 | 422,619 |
| 2024-05-03 | Carmichael Greg D (Director) | Buy | 2,000 | 83.73 | 167,460 |
| 2024-04-30 | Tarr Mark J (President & CEO) | Sale | 44,976 | 83.27 | 3,745,151 |
| 2024-04-30 | Tarr Mark J (President & CEO) | Option Ex | 44,976 | 32.45 | 1,459,246 |
| 2023-11-13 | Coltharp Douglas E (EVP & Chief Financial Officer) | Sale | 11,215 | 63.39 | 710,918 |
| 2023-11-13 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 16,623 | 26.55 | 441,340 |
| 2023-08-17 | Charbonneau Elissa Joy (Chief Medical Officer) | Sale | 8,294 | 69.58 | 577,096 |
| 2023-08-16 | Tarr Mark J (President & CEO) | Sale | 25,330 | 71.06 | 1,799,949 |
| 2023-08-16 | Tarr Mark J (President & CEO) | Option Ex | 25,330 | 26.55 | 672,511 |
| 2023-02-10 | Coltharp Douglas E (EVP & Chief Financial Officer) | Sale | 17,895 | 60.78 | 1,087,658 |
| 2023-02-10 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 17,895 | 20.07 | 359,152 |
| 2022-10-31 | Carmichael Greg D (Director) | Buy | 1,830 | 54.67 | 100,046 |
| 2022-08-17 | Tarr Mark J (President & CEO) | Sale | 20,449 | 53.25 | 1,088,909 |
| 2022-08-17 | Tarr Mark J (President & CEO) | Option Ex | 20,449 | 20.07 | 410,411 |
| 2022-05-06 | O'connor Kevin J. (Director) | Buy | 1,000 | 66.48 | 66,480 |
| 2022-02-08 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 26,132 | 21.02 | 549,294 |
| 2021-12-02 | Williams Terrance (Director) | Buy | 354 | 56.61 | 20,039 |
| 2021-03-08 | Price Andrew L (Chief Accounting Officer) | Sale | 8,589 | 81.40 | 699,144 |
| 2020-11-17 | Charbonneau Elissa Joy (Chief Medical Officer) | Sale | 6,650 | 75.22 | 500,213 |
| 2020-05-28 | Coltharp Douglas E (EVP & Chief Financial Officer) | Sale | 23,501 | 75.94 | 1,784,665 |
| 2020-05-28 | Coltharp Douglas E (EVP & Chief Financial Officer) | Option Ex | 23,501 | 24.21 | 568,959 |
| 2020-05-15 | Jacobsmeyer Barbara Ann (President, Inpatient Hospitals) | Sale | 2,500 | 64.73 | 161,825 |
| 2020-05-14 | Tarr Mark J (President & CEO) | Sale | 26,132 | 61.92 | 1,618,093 |
| 2020-05-14 | Tarr Mark J (President & CEO) | Option Ex | 26,132 | 21.02 | 549,294 |
| 2020-03-12 | Anthony April Kaye Bullock (CEO & President, Home Health) | Buy | 125,000 | 57.99 | 7,248,875 |
| 2020-03-12 | Correll Donald L (Director) | Sale | 2,000 | 59.04 | 118,080 |
| 2020-03-11 | Anthony April Kaye Bullock (CEO & President, Home Health) | Buy | 40,000 | 64.24 | 2,569,600 |
| 2020-03-11 | Higdon Leo I Jr (Director) | Buy | 1,000 | 64.07 | 64,069 |
| 2019-11-05 | Curl Yvonne M (Director) | Buy | 500 | 69.19 | 34,595 |
| 2019-05-01 | Tarr Mark J (President & CEO) | Sale | 67,382 | 63.48 | 4,277,746 |
| 2019-05-01 | Tarr Mark J (President & CEO) | Option Ex | 67,382 | 18.82 | 1,268,129 |
| 2019-03-07 | Higdon Leo I Jr (Director) | Buy | 1,000 | 58.84 | 58,840 |
| 2018-08-14 | Price Andrew L (Chief Accounting Officer) | Sale | 9,457 | 80.04 | 756,938 |
| 2018-08-03 | Levy Cheryl B. (Chief Human Resources Officer) | Sale | 28,955 | 78.00 | 2,258,490 |
| 2018-05-14 | Jacobsmeyer Barbara Ann (President, Inpatient Hospitals) | Sale | 1,798 | 62.73 | 112,788 |
| 2018-05-09 | Levy Cheryl B. (Chief Human Resources Officer) | Sale | 30,982 | 63.00 | 1,951,866 |
| 2018-05-02 | Jacobsmeyer Barbara Ann (President, Inpatient Hospitals) | Sale | 3,897 | 62.51 | 243,601 |
| 2018-05-02 | Jacobsmeyer Barbara Ann (President, Inpatient Hospitals) | Option Ex | 3,897 | 42.22 | 164,531 |
| 2018-05-01 | Tarr Mark J (President & CEO) | Sale | 33,100 | 60.96 | 2,017,776 |
| 2018-05-01 | Tarr Mark J (President & CEO) | Option Ex | 33,100 | 7.85 | 259,835 |
| 2017-11-01 | Curl Yvonne M (Director) | Buy | 1,000 | 45.95 | 45,950 |
| 2017-08-07 | Tarr Mark J (President & CEO) | Sale | 22,625 | 43.00 | 972,875 |
| 2017-08-07 | Tarr Mark J (President & CEO) | Option Ex | 22,625 | 16.27 | 368,108 |
| 2017-08-03 | Tarr Mark J (President & CEO) | Sale | 22,625 | 42.55 | 962,693 |
| 2017-08-03 | Tarr Mark J (President & CEO) | Option Ex | 22,625 | 16.27 | 368,108 |
| 2017-02-10 | Price Andrew L (Chief Accounting Officer) | Option Ex | 15,000 | 23.19 | 347,850 |
| 2016-11-29 | Grinney Jay (Pres & Chief Executive Officer) | Option Ex | 130,000 | 23.19 | 3,014,700 |
| 2016-11-09 | Tarr Mark J (EVP and COO) | Buy | 6,371 | 39.29 | 250,316 |
| 2016-11-09 | Coltharp Douglas E (EVP & Chief Financial Officer) | Buy | 6,450 | 39.14 | 252,453 |
| 2016-08-02 | Tarr Mark J (EVP and COO) | Sale | 20,000 | 41.85 | 837,060 |
| 2016-08-02 | Tarr Mark J (EVP and COO) | Option Ex | 20,000 | 23.19 | 463,800 |
| 2016-04-29 | Levy Cheryl B. (Chief Human Resources Officer) | Sale | 11,000 | 41.44 | 455,840 |
| 2016-04-29 | Levy Cheryl B. (Chief Human Resources Officer) | Option Ex | 11,000 | 24.06 | 264,660 |
| 2016-03-01 | Fay Edmund (Sr. Vice Pres. and Treasurer) | Sale | 13,440 | 35.50 | 477,120 |
| 2016-02-29 | Fay Edmund (Sr. Vice Pres. and Treasurer) | Sale | 2,800 | 35.50 | 99,400 |
| 2016-02-02 | Price Andrew L (Chief Accounting Officer) | Option Ex | 9,000 | 35.84 | 322,578 |
| 2016-01-29 | Tarr Mark J (EVP and COO) | Option Ex | 12,000 | 26.55 | 318,600 |
| 2016-01-29 | Grinney Jay (Pres & Chief Executive Officer) | Option Ex | 150,000 | 26.55 | 3,982,500 |
| 2016-01-11 | Chidsey John (Director) | Buy | 799 | 35.77 | 28,584 |
| 2015-11-16 | Charbonneau Elissa Joy (Chief Medical Officer) | Buy | 294 | 33.68 | 9,900 |
| 2015-11-05 | Herman Joan E (Director) | Buy | 1,000 | 35.28 | 35,278 |
| 2015-11-02 | Higdon Leo I Jr (Director) | Buy | 1,000 | 34.81 | 34,810 |
| 2015-08-11 | Tarr Mark J (EVP and COO) | Option Ex | 7,029 | 19.35 | 136,011 |
| 2015-07-31 | Clohan Dexanne B (Chief Medical Officer) | Option Ex | 21,000 | 23.27 | 488,670 |
| 2015-03-09 | Grinney Jay (Pres & Chief Executive Officer) | Option Ex | 130,000 | 26.85 | 3,490,500 |
| 2015-02-27 | Price Andrew L (Chief Accounting Officer) | Sale | 1,145 | 43.84 | 50,201 |
| 2015-02-27 | Price Andrew L (Chief Accounting Officer) | Option Ex | 4,000 | 26.85 | 107,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of EHC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Encompass Health Corp (symbol EHC, CIK number 785161) see the Securities and Exchange Commission (SEC) website.